FBRX Forte Biosciences, Inc. - Common Stock
$76,86
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 12, 2026
Rango 52S
$10–$77
99% of range
Calificación del Analista
HOLD
11 analysts
Precio Objetivo
$74
P/E (TTM)
-16.3
ROE
-86.9%
Margen de Beneficio Neto
-2555.2%
FBRX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$76.86
Capitalización Bursátil
$995M
P/E (TTM)
-16.3
BPA (TTM)
$-4.71
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-86.9%
Deuda/Capital
—
Rango 52S
$10 – $77
FBRX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
2016-12-31
→
2019-12-31
BPA
$-4.71
2021-12-31
→
2025-12-31
Flujo de caja libre
$-51M
2017-12-31
→
2025-12-31
Márgenes
-2555.2%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
FBRX
Mediana de Pares
P/E (TTM)
-16.3
—
P/S (TTM) (P/V (TTM))
55.2
22.4
P/B (P/C)
16.3
2.7
Price / FCF (Precio / FCF)
-19.5
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
FBRX
Mediana de Pares
Operating Margin (Margen Operativo)
-2602.5%
—
Net Profit Margin (Margen de Beneficio Neto)
-2555.2%
-638.9%
ROA
-96.1%
-43.1%
ROE
-86.9%
-49.0%
ROIC
-117.6%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
FBRX
Mediana de Pares
Current Ratio (Ratio corriente)
3.9
9.0
Quick Ratio (Ratio Rápido)
3.7
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
FBRX
Mediana de Pares
Revenue YoY (Ingresos interanuales)
106.6%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
155.9%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
FBRX
Mediana de Pares
FBRX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
11 analistas
- Compra fuerte 2 18,2%
- Compra 4 36,4%
- Mantener 5 45,5%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-13
Mediana
$77.00
Media
$73.80
Ahora
$76.86
Mín
$61.00
Máx
$77.00
Objetivo mediano
$77.00
+0,2%
Objetivo medio
$73.80
-4,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.07%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.97 | $-0.90 | -0.07% |
| 31 de marzo de 2026 | $-1.24 | $-1.22 | -0.02% |
| 31 de diciembre de 2025 | $-1.39 | $-1.24 | -0.15% |
| 30 de septiembre de 2025 | $-0.99 | $-1.09 | 0.10% |
| 30 de junio de 2025 | $-0.96 | $-1.13 | 0.17% |
| 31 de marzo de 2025 | $-1.37 | $-0.97 | -0.40% |
| 31 de diciembre de 2024 | $-2.45 | $-3.34 | 0.89% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| TRAX | — | — | — | — | — | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $36.0K | $18M | $41.0K | $49.0K | |
| R&D Expense | · | · | · | · | · | · | $45M | $51M | $29M | $27M | |
| SG&A Expense | $12M | $15M | $11M | $8M | $8M | $4M | $1M | $13M | $9M | $5M | |
| Operating Expenses | $71M | $37M | $32M | $14M | $21M | $46M | $4M | $64M | $38M | $32M | |
| Operating Income | $-71M | $-37M | $-32M | $-14M | $-21M | $-46M | $-4M | $-46M | $-38M | $-32M | |
| Other Non-op | $-396.0K | $-190.0K | $-114.0K | $-145.0K | $-222.0K | $-205.0K | $-5.0K | · | $-1M | $-2M | |
| Pretax Income | $-68M | $-35M | $-31M | · | · | · | $-64M | $-47M | $-39M | $-33M | |
| Income Tax | $1M | $0 | · | · | · | · | $1.0K | $2M | $1.0K | $1.0K | |
| Net Income | $-69M | $-35M | $-31M | $-14M | $-22M | $-46M | $-4M | $-49M | $-39M | $-33M | |
| EPS (Basic) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | · | · | · | · | · | |
| EPS (Diluted) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 17,383,531 | 13,967,818 | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | 17,383,531 | 13,967,818 | · | · | · | · | · | |
| EBITDA | $-71M | $-37M | · | · | $-21M | $-46M | · | $-46M | $-38M | · |
Balance general 23
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $22M | $37M | $41M | $42M | $59M | $7M | $41M | $36M | $6M | |
| Short-term Investments | $0 | $36M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $3M | $1M | $411.0K | $476.0K | $1M | $567.0K | $2M | $2M | $1M | |
| Current Assets | $81M | $61M | $38M | $42M | $43M | $60M | $8M | $98M | $91M | $32M | |
| PP&E (Net) | $129.0K | $77.0K | $109.0K | · | · | $97.0K | $152.0K | $4M | $1M | $743.0K | |
| PP&E (Gross) | $241.0K | $125.0K | $118.0K | · | · | · | $3M | $7M | $4M | $3M | |
| Accum. Depreciation | $112.0K | $48.0K | $9.0K | · | · | · | $2M | $3M | $3M | $2M | |
| Other Non-current Assets | $2M | $138.0K | $544.0K | $486.0K | $786.0K | $1M | $0 | $1M | $227.0K | $2M | |
| Total Assets | $83M | $62M | $39M | $42M | $43M | $61M | $8M | $103M | $92M | $35M | |
| Accounts Payable | $10M | $5M | $1M | $1M | $946.0K | $1M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $11M | $4M | $2M | $2M | $812.0K | $1M | $343.0K | $13M | $8M | $5M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | $7M | $7M | |
| Current Liabilities | $21M | $9M | $4M | $3M | $2M | $2M | $2M | $17M | $17M | $14M | |
| Capital Leases | · | · | · | · | · | · | $4M | · | · | · | |
| Other Non-current Liabilities | $1M | · | · | · | · | · | $81.0K | · | · | · | |
| Total Liabilities | $22M | $9M | · | · | · | · | $17M | $45M | $21M | $28M | |
| Total Debt | · | · | · | · | · | · | · | $26M | $11M | · | |
| Common Stock | $13.0K | $6.0K | $1.0K | $21.0K | $15.0K | $13.0K | $2.0K | $23.0K | $20.0K | $2.0K | |
| Retained Earnings | $-223M | $-154M | $-119M | $-87M | $-73M | $-51M | $-5M | $-216M | $-167M | $-128M | |
| AOCI | $3.0K | $11.0K | $4.0K | · | · | · | $10.0K | $-23.0K | $-34.0K | · | |
| Stockholders' Equity | $61M | $52M | $35M | $39M | $42M | $59M | $-5M | $-736.0K | $71M | $-124M | |
| Liabilities + Equity | $83M | $62M | $39M | $42M | $43M | $61M | $8M | $103M | $92M | $35M | |
| Shares Outstanding | 12,948,308 | 6,393,323 | 1,453,402 | 21,000,069 | 14,754,447 | 12,830,598 | 2,108,266 | 23,000,151 | 19,882,551 | 2,202,517 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $3M | $3M | $4M | $4M | $956.0K | $36.0K | $7M | $4M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | |
| Operating Cash Flow | $-51M | $-31M | $-29M | $-8M | $-17M | $-18M | $-3M | $-34M | $-31M | $-30M | |
| CapEx | $116.0K | $37.0K | $88.0K | · | · | · | $162.0K | $2M | $655.0K | $525.0K | |
| Investing Cash Flow | $36M | $-36M | $47.0K | · | · | $4M | $-162.0K | $-4M | $-28M | $25M | |
| Stock Issued | $2M | $0 | · | $7M | · | $67M | $551.0K | $661.0K | $507.0K | $10.0K | |
| Net Stock Activity | $2M | · | · | · | · | $67M | · | $661.0K | $507.0K | · | |
| Financing Cash Flow | $69M | $52M | $25M | $7M | $-44.0K | $67M | $5M | $44M | $89M | $2M | |
| Net Change in Cash | $55M | $-15M | $-4M | $-944.0K | $-17M | $52M | $2M | $5M | $30M | $-3M | |
| Free Cash Flow | $-51M | $-31M | · | · | · | · | · | $-36M | $-32M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2602.5% | -2785.5% | · | · | · | · | · | -254.2% | · | · | |
| Net Margin | -2555.2% | -2700.0% | · | · | · | · | · | -271.4% | · | · | |
| Pretax Margin | -2517.1% | -2700.0% | · | · | · | · | · | -262.0% | · | · | |
| EBITDA Margin | -2602.5% | -2785.5% | · | · | · | · | · | -254.2% | · | · | |
| ROA | -96.1% | -70.6% | · | · | -41.5% | -134.9% | · | -50.2% | -61.1% | · | |
| ROE | -86.9% | -114.7% | · | · | -51.0% | -117.2% | · | -92.5% | 146.0% | · | |
| ROIC | -117.6% | · | · | · | · | · | · | -56.3% | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 6.8 | · | · | 24.2 | 26.5 | · | 5.9 | 5.2 | · | |
| Quick Ratio | 3.7 | 6.4 | · | · | 23.9 | 26.0 | · | 2.5 | 2.1 | · | |
| Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.2 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.1 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | 0.2 | · | · |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 106.6% | 16.9% | 593.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 155.9% | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $18M | $18M | $18M | $18M | $18M | $36.0K | $18M | $41.0K | · | |
| Net Income TTM | $-69M | $-35M | $-31M | $-14M | $-22M | $-46M | $-4M | $-49M | $-39M | · | |
| Market Cap | $353M | $145M | · | · | $789M | $11.68B | · | $70.81B | $76.42B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $70.80B | $76.40B | · | |
| P/E | -5.8 | -1.9 | -0.8 | -31.2 | -34.5 | · | · | · | · | · | |
| P/S | 19.6 | 8.1 | · | · | 43.8 | 647.5 | · | 3926.1 | 1863989.2 | · | |
| P/B | 5.8 | 2.8 | · | · | 19.0 | 198.0 | · | 1217.8 | 1075.1 | · | |
| P / Tangible Book | 5.8 | 2.8 | 21.1 | 13.5 | 19.0 | 198.0 | · | · | · | · | |
| P / Cash Flow | -6.9 | -4.7 | · | · | -47.3 | -633.9 | · | -2054.4 | -2454.7 | · | |
| P / FCF | -6.9 | -4.7 | · | · | · | · | · | -1943.4 | -2404.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -1544.0 | -2030.3 | · | |
| EV / FCF | · | · | · | · | · | · | · | -1943.0 | -2403.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 3925.3 | 1863376.8 | · | |
| Earnings Yield | -17.3% | -53.6% | -121.3% | -3.2% | -2.9% | · | · | · | · | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $7M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $25M | $22M | $25M | $18M | $12M | $16M | $7M | $9M | $13M | $8M | $6M | $10M | $9M | $7M | $5M | $3M | |
| Operating Income | $-25M | $-22M | $-25M | $-18M | $-12M | $-16M | $-7M | $-9M | $-13M | $-8M | $-6M | $-10M | $-9M | $-7M | $-5M | $-3M | |
| Other Non-op | $1M | $676.0K | $-2M | $701.0K | $330.0K | $468.0K | $-1M | $237.0K | $307.0K | $384.0K | $-615.0K | $261.0K | $138.0K | $102.0K | $-100.0K | $23.0K | |
| Pretax Income | $-23M | $-22M | · | · | $-11M | $-16M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $193.0K | $373.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-23M | $-22M | $-25M | $-18M | $-11M | $-16M | $-7M | $-8M | $-13M | $-7M | $-6M | $-10M | $-9M | $-7M | $-5M | $-3M | |
| EPS (Basic) | $-0.97 | $-1.24 | $-1.39 | $-0.99 | $-0.96 | $-1.37 | $3.18 | $-4.54 | $-6.78 | $-4.03 | $-17.61 | $-6.57 | $-0.42 | $-0.32 | $-0.24 | $-0.18 | |
| EPS (Diluted) | $-0.97 | $-1.24 | $-1.39 | $-0.99 | $-0.96 | $-1.37 | $3.18 | $-4.54 | $-6.78 | $-4.03 | $-17.61 | $-6.57 | $-0.42 | $-0.32 | $-0.24 | $-0.18 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | 21,046,831 | 21,006,680 | · | 18,927,446 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | 21,046,831 | 21,006,680 | · | 18,927,446 | |
| EBITDA | $-25M | $-22M | · | $-18M | $-12M | $-16M | · | $-9M | $-13M | $-8M | · | $-10M | $-9M | $-7M | · | $-3M |
Balance general 20
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $58M | $77M | $93M | $106M | $46M | $22M | $16M | $24M | $30M | $37M | $46M | $20M | $36M | $41M | $44M | |
| Short-term Investments | $149M | · | · | · | · | · | $36M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $7M | $4M | $2M | $1M | $1M | $3M | $1M | $1M | $1M | $1M | $917.0K | $322.0K | $369.0K | $411.0K | $546.0K | |
| Current Assets | $203M | $65M | $81M | $95M | $108M | $47M | $61M | $18M | $26M | $32M | $38M | $47M | $31M | $36M | $42M | $45M | |
| PP&E (Net) | $90.0K | $110.0K | $129.0K | $148.0K | $110.0K | $125.0K | $77.0K | $86.0K | $96.0K | $106.0K | $109.0K | $98.0K | $30.0K | · | · | · | |
| PP&E (Gross) | $241.0K | $241.0K | $241.0K | $241.0K | $186.0K | $186.0K | $125.0K | $124.0K | $124.0K | $124.0K | $118.0K | · | · | · | · | · | |
| Accum. Depreciation | $151.0K | $131.0K | $112.0K | $93.0K | $76.0K | $61.0K | $48.0K | $38.0K | $28.0K | $18.0K | $9.0K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $2M | $57.0K | $176.0K | $138.0K | $192.0K | $271.0K | $409.0K | $544.0K | $679.0K | $407.0K | $437.0K | $486.0K | $534.0K | |
| Total Assets | $206M | $67M | $83M | $97M | $108M | $47M | $62M | $18M | $26M | $32M | $39M | $48M | $31M | $37M | $42M | $45M | |
| Accounts Payable | $14M | $13M | $10M | $5M | $5M | $5M | $5M | $5M | $5M | $2M | $1M | $5M | $3M | $1M | $1M | $1M | |
| Accrued Liabilities | $6M | $11M | $11M | $8M | $4M | $4M | $4M | $3M | $4M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | |
| Current Liabilities | $20M | $24M | $21M | $13M | $9M | $9M | $9M | $9M | $9M | $3M | $4M | $7M | $6M | $4M | $3M | $2M | |
| Other Non-current Liabilities | $2M | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $22M | $25M | $22M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $21.0K | $14.0K | $13.0K | $13.0K | $12.0K | $6.0K | $6.0K | $1.0K | $36.0K | $36.0K | $1.0K | $36.0K | $21.0K | $21.0K | $21.0K | $21.0K | |
| Retained Earnings | $-269M | $-246M | $-223M | $-199M | $-181M | $-170M | $-154M | $-147M | $-138M | $-126M | $-119M | $-113M | $-103M | $-94M | $-87M | $-82M | |
| AOCI | $-54.0K | $-4.0K | $3.0K | $-6.0K | · | · | $11.0K | $1.0K | $-7.0K | $-2.0K | $4.0K | $-5.0K | $1.0K | · | · | · | |
| Stockholders' Equity | $184M | $42M | $61M | $84M | $99M | $38M | $52M | $9M | $17M | $29M | $35M | $40M | $25M | $33M | $39M | $43M | |
| Liabilities + Equity | $206M | $67M | $83M | $97M | $108M | $47M | $62M | $18M | $26M | $32M | $39M | $48M | $31M | $37M | $42M | $45M | |
| Shares Outstanding | 20,482,400 | 13,910,668 | 12,948,308 | 12,523,845 | 12,282,024 | 6,581,667 | 6,393,323 | 1,460,007 | 36,442,380 | 36,394,882 | 1,453,402 | 36,281,772 | 21,051,195 | 21,007,069 | 21,000,069 | 21,000,069 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $2M | $1M | $1M | $2M | $697.0K | $791.0K | $802.0K | $805.0K | $780.0K | $772.0K | $855.0K | $877.0K | $860.0K | $906.0K | |
| Operating Cash Flow | $-23M | $-19M | $-16M | $-14M | $-10M | $-10M | $-10M | $-8M | $-6M | $-7M | $-9M | $-9M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $0 | $0 | $0 | $55.0K | $0 | $61.0K | $31.0K | $0 | $0 | $6.0K | $17.0K | · | · | · | · | · | |
| Investing Cash Flow | $-148M | $0 | $0 | $-55.0K | $0 | $36M | $-36M | $0 | $0 | $-6.0K | $-16.0K | $10M | · | · | · | · | |
| Stock Issued | · | · | $0 | $-73M | · | · | · | · | $0 | $8.0K | · | $25M | $0 | $6.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $8.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $162M | $74.0K | $9.0K | $1M | $70M | $-2M | $52M | $-2.0K | $-10.0K | $-8.0K | $-75.0K | $25M | $-24.0K | $6.0K | $-55.0K | $7M | |
| Net Change in Cash | $-9M | $-19M | $-16M | $-13M | $60M | $24M | $6M | $-8M | $-6M | $-7M | $-9M | $26M | $-15M | $-5M | $-3M | $6M | |
| Free Cash Flow | · | $-19M | · | · | · | $-10M | · | · | · | $-7M | · | · | · | · | · | · |
Rentabilidad 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.9% | -38.6% | · | -30.7% | -16.8% | -39.4% | · | -25.5% | -43.7% | -21.6% | · | -21.4% | -25.1% | -17.3% | · | -7.3% | |
| ROE | -16.5% | -55.0% | · | -37.8% | -19.5% | -46.7% | · | -33.7% | -59.8% | -24.1% | · | -23.9% | -28.2% | -18.5% | · | -7.9% | |
| ROIC | -13.5% | -54.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 2.8 | · | 7.3 | 11.7 | 5.2 | · | 2.1 | 2.8 | 9.5 | · | 6.3 | 4.9 | 9.6 | · | 19.4 | |
| Quick Ratio | 9.8 | 2.5 | · | 7.2 | 11.6 | 5.1 | · | 1.9 | 2.7 | 9.1 | · | 6.2 | 3.2 | 9.5 | · | 19.2 |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | |
| Net Income TTM | $-74M | $-67M | · | $-53M | $-48M | $-44M | · | $-38M | $-39M | $-33M | · | $-29M | $-22M | $-16M | · | $-17M | |
| Market Cap | $435M | $360M | · | $188M | $159M | $51M | · | $8M | $489M | $633M | · | $600M | $547M | $530M | · | $562M | |
| P/E | -5.1 | -5.7 | · | -1.9 | -0.9 | -0.5 | · | -0.3 | -0.8 | -1.5 | · | -2.2 | -23.0 | -28.7 | · | -24.3 | |
| P/S | 24.1 | 20.0 | · | 10.4 | 8.8 | 2.8 | · | 0.5 | 27.1 | 35.1 | · | 33.3 | 30.3 | 29.4 | · | 31.1 | |
| P/B | 2.4 | 8.6 | · | 2.2 | 1.6 | 1.3 | · | 0.9 | 28.8 | 22.1 | · | 14.9 | 22.0 | 16.1 | · | 13.1 | |
| P / Tangible Book | 2.4 | 8.6 | · | 2.2 | 1.6 | 1.3 | · | 0.9 | 28.8 | 22.1 | · | 14.9 | 22.0 | 16.1 | · | 13.1 | |
| P / Cash Flow | · | -19.2 | · | · | · | -4.9 | · | · | · | -95.0 | · | · | · | -101.9 | · | · | |
| P / FCF | · | -19.2 | · | · | · | -4.9 | · | · | · | -94.9 | · | · | · | · | · | · | |
| Earnings Yield | -19.6% | -17.6% | · | -52.4% | -105.6% | -215.5% | · | -392.1% | -132.6% | -65.2% | · | -45.3% | -4.3% | -3.5% | · | -4.1% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | -2602.5% | -2785.5% | — | — | — |
| Beneficio neto | $-69M | $-35M | $-31M | $-14M | $-22M |
| EPS Diluido | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.9 | 6.8 | — | — | 24.2 |
| Ratio Rápido | 3.7 | 6.4 | — | — | 23.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-51M | $-31M | — | — | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 91 declarantes · $409.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 34 (+15 vs trimestre anterior) | 13 (+6 vs trimestre anterior) | 30 (+13 vs trimestre anterior) | 16 (-4 vs trimestre anterior) | +5.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $44 848 465 | 2 110 516 | 10,94% | Acciones |
| ORBIMED ADVISORS LLC | $33 526 231 | 1 577 705 | 8,18% | Acciones |
| JANUS HENDERSON GROUP PLC | $30 812 336 | 1 188 060 | 7,52% | Acciones |
| FRED ALGER MANAGEMENT, LLC | $30 593 561 | 1 439 697 | 7,47% | Acciones |
| Affinity Asset Advisors, LLC | $24 339 559 | 1 145 391 | 5,94% | Acciones |
| MPM BIOIMPACT LLC | $20 983 270 | 987 448 | 5,12% | Acciones |
| TCG Crossover Management, LLC | $19 550 000 | 920 000 | 4,77% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $18 311 911 | 861 737 | 4,47% | Acciones |
| Woodline Partners LP | $15 146 001 | 712 753 | 3,70% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $14 875 000 | 700 000 | 3,63% | Acciones |
| Integral Health Asset Management, LLC | $14 343 750 | 675 000 | 3,50% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $13 922 979 | 655 199 | 3,40% | Acciones |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $11 799 705 | 786 647 | 2,88% | Acciones |
| CITADEL ADVISORS LLC | $11 388 789 | 535 943 | 2,78% | Acciones |
| FMR LLC | $10 685 053 | 502 826 | 2,61% | Acciones |
| AMERIPRISE FINANCIAL INC | $8 898 586 | 418 757 | 2,17% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $8 502 392 | 400 003 | 2,07% | Acciones |
| Cable Car Capital, LP | $8 500 000 | 400 000 | 2,07% | Acciones |
| STATE STREET CORP | $6 981 093 | 328 522 | 1,70% | Acciones |
| Candriam S.C.A. | $6 434 678 | 303 100 | 1,57% | Acciones |
| Boxer Capital Management, LLC | $5 833 125 | 274 500 | 1,42% | Acciones |
| Trails Edge Capital Partners, LP | $5 805 097 | 273 181 | 1,42% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $5 305 976 | 249 693 | 1,29% | Acciones |
| Squadron Capital Management LLC | $4 781 250 | 225 000 | 1,17% | Acciones |
| AWM Investment Company, Inc. | $4 728 125 | 222 500 | 1,15% | Acciones |
| UBS Group AG | $3 463 198 | 162 974 | 0,85% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 893 698 | 136 174 | 0,71% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 842 634 | 133 771 | 0,69% | Acciones |
| Nuveen, LLC | $2 302 374 | 108 347 | 0,56% | Acciones |
| VANGUARD GROUP INC | $1 842 770 | 67 575 | 0,45% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 797 750 | 84 600 | 0,44% | Opción de venta |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $999 664 | 47 043 | 0,24% | Acciones |
| J. Goldman & Co LP | $981 368 | 46 182 | 0,24% | Acciones |
| Balyasny Asset Management L.P. | $826 583 | 38 898 | 0,20% | Acciones |
| MANGROVE PARTNERS IM, LLC | $708 603 | 33 346 | 0,17% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $639 795 | 30 108 | 0,16% | Acciones |
| XTX Topco Ltd | $636 374 | 29 947 | 0,16% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $559 470 | 26 328 | 0,14% | Acciones |
| Trexquant Investment LP | $534 820 | 25 168 | 0,13% | Acciones |
| Weil Company, Inc. | $526 256 | 24 765 | 0,13% | Acciones |
| AlphaQuest LLC | $512 785 | 18 804 | 0,13% | Acciones |
| RHUMBLINE ADVISERS | $470 662 | 22 149 | 0,11% | Acciones |
| Ikarian Capital, LLC | $445 655 | 20 972 | 0,11% | Acciones |
| JANE STREET GROUP, LLC | $418 370 | 19 688 | 0,10% | Acciones |
| Persistent Asset Partners Ltd | $388 089 | 18 263 | 0,09% | Acciones |
| WELLS FARGO & COMPANY/MN | $375 360 | 17 664 | 0,09% | Acciones |
| Russell Investments Group, Ltd. | $349 180 | 16 432 | 0,09% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $346 162 | 16 290 | 0,08% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304 109 | 14 311 | 0,07% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $293 250 | 13 800 | 0,07% | Opción de compra |
| TWO SIGMA INVESTMENTS, LP | $284 984 | 13 411 | 0,07% | Acciones |
| Squarepoint Ops LLC | $261 736 | 12 317 | 0,06% | Acciones |
| BANK OF AMERICA CORP /DE/ | $251 345 | 11 828 | 0,06% | Acciones |
| MetLife Investment Management, LLC | $243 759 | 11 471 | 0,06% | Acciones |
| Bank of New York Mellon Corp | $237 958 | 11 198 | 0,06% | Acciones |
| GOLDMAN SACHS GROUP INC | $236 576 | 11 133 | 0,06% | Acciones |
| BlackRock, Inc. | $218 153 | 10 266 | 0,05% | Acciones |
| ExodusPoint Capital Management, LP | $217 239 | 10 223 | 0,05% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $188 700 | 8 880 | 0,05% | Acciones |
| China Universal Asset Management Co., Ltd. | $170 000 | 8 000 | 0,04% | Acciones |
| CITIGROUP INC | $169 660 | 7 984 | 0,04% | Acciones |
| Invesco Ltd. | $164 114 | 7 723 | 0,04% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $144 500 | 6 800 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $142 418 | 6 702 | 0,03% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $121 380 | 5 712 | 0,03% | Acciones |
| NORTHERN TRUST CORP | $64 558 | 3 038 | 0,02% | Acciones |
| BARCLAYS PLC | $58 438 | 2 750 | 0,01% | Acciones |
| Tower Research Capital LLC (TRC) | $45 475 | 2 140 | 0,01% | Acciones |
| Legal & General Group Plc | $39 950 | 1 880 | 0,01% | Acciones |
| Ameritas Investment Partners, Inc. | $37 358 | 1 758 | 0,01% | Acciones |
| STRS OHIO | $36 125 | 1 700 | 0,01% | Acciones |
| Quantbot Technologies LP | $30 685 | 1 444 | 0,01% | Acciones |
| State of Wyoming | $21 675 | 1 020 | 0,01% | Acciones |
| ROYAL BANK OF CANADA | $16 000 | 748 | 0,00% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $12 155 | 572 | 0,00% | Acciones |
| Steward Partners Investment Advisory, LLC | $10 476 | 493 | 0,00% | Acciones |
| DEUTSCHE BANK AG\ | $7 884 | 371 | 0,00% | Acciones |
| LORD, ABBETT & CO. LLC | $4 472 | 210 442 | 0,00% | Acciones |
| COMERICA BANK | $4 091 | 150 | 0,00% | Acciones |
| FIFTH THIRD BANCORP | $3 188 | 150 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $2 401 | 113 | 0,00% | Acciones |
| GROUP ONE TRADING LLC | $2 210 | 104 | 0,00% | Acciones |
| Sterling Capital Management LLC | $1 445 | 68 | 0,00% | Acciones |
| MORGAN STANLEY | $829 | 39 | 0,00% | Acciones |
| ASSETMARK, INC | $723 | 34 | 0,00% | Acciones |
| Quarry LP | $574 | 27 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $338 | 15 900 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $256 | 12 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $255 | 12 | 0,00% | Acciones |
| REAP Financial Group, LLC | $64 | 3 | 0,00% | Acciones |
| Allworth Financial LP | $22 | 1 | 0,00% | Acciones |
Informantes de la empresa 26 insiders · 9 directivos · 19 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Paul A. Wagner | CEO, Secretary and Chair of the Board | 1 de julio de 2026 M | 85 482 | 0 | 0 | $0 |
| Martin J Duvall | Chief Executive Officer | 4 de octubre de 2019 A | 13 605 | 0 | 0 | $0 |
| Antony A Riley | CHIEF FINANCIAL OFFICER | 1 de julio de 2026 M | 42 600 | 1 | 0 | $254 874 |
| Mark G Foletta | EVP & Chief Financial Officer | 4 de octubre de 2019 A | 15 042 | 0 | 0 | $0 |
| Hubert C Chen | President and Chief Scientific Officer | 1 de enero de 2024 M | 93 405 | 0 | 0 | $0 |
| Harry E Gruber | President, Science&Innovation | 26 de febrero de 2020 A | 23 685 | 0 | 0 | $0 |
| Fairooz Kabbinavar | SVP Clinical Development | 4 de octubre de 2019 A | — | 0 | 0 | $0 |
| Douglas Jolly | EVP, Research & Pharm Devel | 4 de octubre de 2019 A | 393 478 | 0 | 0 | $0 |
| Asha Das | SVP & Chief Medical Officer | 1 de marzo de 2018 A | 5 000 | 0 | 0 | $0 |
| Shivpreet Singh Kapoor | Consejero | 29 de mayo de 2026 A | — | 0 | 0 | $0 |
| Scott C. Brun | Consejero | 29 de mayo de 2026 A | — | 0 | 0 | $0 |
| Steven Kornfeld | Consejero | 29 de mayo de 2026 A | 99 009 | 0 | 0 | $0 |
| Stephen K Doberstein | Consejero | 29 de mayo de 2026 A | — | 0 | 0 | $0 |
| Richard G Vincent | Consejero | 29 de mayo de 2026 A | — | 0 | 0 | $0 |
| David W Gryska | Consejero | 29 de mayo de 2026 A | 148 514 | 0 | 0 | $0 |
| Lawrence Eichenfield | Consejero | 19 de septiembre de 2023 A | — | 0 | 0 | $0 |
| Donald Allen Williams | Consejero | 19 de septiembre de 2023 A | 59 405 | 0 | 0 | $0 |
| Barbara K Finck | Consejero | 19 de septiembre de 2023 A | — | 0 | 0 | $0 |
| Patricia S Walker | Consejero | 1 de junio de 2022 A | — | 0 | 0 | $0 |
| Thomas E Darcy | Consejero | 13 de enero de 2021 M | 2 358 | 0 | 0 | $0 |
| Lori Anne Kunkel | Consejero | 4 de octubre de 2019 A | — | 0 | 0 | $0 |
| David Ross Parkinson | Consejero | 4 de octubre de 2019 A | — | 0 | 0 | $0 |
| Faheem Hasnain | Consejero | 4 de octubre de 2019 A | 245 857 | 0 | 0 | $0 |
| Franklin M Berger | Consejero | 4 de octubre de 2019 A | 25 335 | 0 | 0 | $0 |
| SCHIMMEL PAUL | Consejero | 4 de octubre de 2019 A | 13 623 | 0 | 0 | $0 |
| Steven Michael Oliveira | Propietario del 10% | 14 de abril de 2020 P | 2 873 450 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 6 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, Eric Shahinian, ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg, Michael G. Hacke, McIntyre Partnerships, LP, McIntyre Capital GP, LLC, McIntyre Capital Management, LP, McIntyre Capital Management GP, LLC, Chris McIntyre ×11 presentaciones | 17 de junio de 2024 | — | Presentación inicial | — | SEC |
| BML Investment Partners, L.P. ×6 presentaciones | 11 de enero de 2024 | — | Presentación inicial | — | SEC |
| Funicular Funds, LP, Jacob Ma-Weaver ×6 presentaciones | 9 de enero de 2024 | — | Presentación inicial | — | SEC |
| Paul A. Wagner, Ph.D. (2) ×2 presentaciones | 15 de agosto de 2023 | — | Presentación inicial | — | SEC |
| ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg ×2 presentaciones | 10 de agosto de 2023 | — | Presentación inicial | — | SEC |
| Paul A. Wagner, Ph.D. | 25 de junio de 2020 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 13 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,34% | 65 797 SH | 8 de agosto de 2026 | Diario |
| SBIO · ALPS ETF Trust | 0,15% | 12 912 NS | 31 de mayo de 2026 | N-PORT |
| IWO · iShares Trust | 0,09% | 177 467 SH | 8 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 1 757 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,05% | 485 030 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 20 646 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 111 500 SH | 8 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 30 190 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 5 159 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1 062 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 217 359 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 622 927 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 625 SH | 8 de agosto de 2026 | Diario |